AAR reports third quarter fiscal year 2026 results
THIRD QUARTER FISCAL YEAR 2026 HIGHLIGHTS
(As compared to Q3 FY2025)
-
Sales of
$845 million ; increased 25% -
GAAP diluted EPS of
$1.71 -
Adjusted diluted EPS of
$1.25 ; increased 26% -
GAAP Net income of
$68 million -
Adjusted EBITDA of
$102 million ; increased 26% - Adjusted EBITDA margin increased to 12.1% from 12.0%
"AAR delivered another outstanding quarter, continuing our momentum. Total sales were up 25%, including 14% organic adjusted sales growth," stated
"Our continued strong revenue growth translated to an adjusted EBITDA increase of 26% in the quarter, and we expanded our adjusted EBITDA margins from 12.0% to 12.1% year over year. We expect continued margin expansion as we shift our sales mix to higher margin offerings as well as realize synergies from our recent acquisitions.
"Regarding acquisitions, the execution of our integration and performance improvement plan for
"We also made solid progress with respect to our leverage. Cash from operations was
Holmes concluded, "We see significant opportunity for continued profitable growth ahead, supported by resilient and growing demand for our aviation aftermarket solutions. We are closely following the conflict in the
RECENT UPDATES
- Commenced exclusive distribution agreement with TRIUMPH for its actuation power line on Boeing and Airbus commercial platforms
- Recently awarded new multi-year contracts with the
U.S. Air Force to repair and build new pallets at our Mobility Systems location worth up to$450 million - Completed Oklahoma City Airframe MRO facility expansion, inducted first aircraft in early March
- Trax signed a multi-year contract expansion with
Air Atlanta Icelandic to add eMobility and cloud hosting solutions to its current eMRO platform offering - Signed a new agreement with
Otto Instrument Service to distribute the LASEREF IV inertial reference system product line, further broadening our new parts Distribution activities in the business aviation market
THIRD QUARTER FISCAL YEAR 2026 RESULTS
Consolidated third quarter sales increased 25% to
The Company reported net income of
Selling, general, and administrative expenses were
Operating margins were 7.8% in the quarter, compared to 10.5% in the prior year quarter. Adjusted operating margin increased to 10.2% in the current year quarter from 9.7% in the prior year quarter, primarily as a result of increased volume and profitability in the Company's new parts Distribution activities.
Net interest expense for the quarter was
Cash flow provided by operating activities was
FOURTH QUARTER AND FULL YEAR FY2026 GUIDANCE
The Company is providing the following guidance for the fourth quarter and full year fiscal 2026:
|
|
Fourth quarter FY2026
As of |
|
Total sales growth |
19% - 21% |
|
Organic sales growth1 |
6% - 8% |
|
Adjusted operating margin |
10.2% - 10.5% |
|
1 Organic sales growth reflects growth from prior year adjusted organic sales for the relevant period, which excludes Landing Gear sales and impact of acquisitions completed in FY2026. |
|
|
Full year FY2026 |
|
|
Prior
As of |
Current
As of |
|
|
Total sales growth |
Approaching 17% |
~19% |
|
Organic sales growth1 |
Approaching 11% |
~12% |
Conference call information
On
The slides are also available on AAR's website at https://www.aarcorp.com/en/investors/quarterly-results/.
About AAR
AAR is a global aerospace and defense aftermarket solutions company with operations in over 20 countries. Headquartered in the
Contact:
This press release contains certain statements relating to future results, which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, which reflect management's expectations about future conditions, including, but not limited to, our fourth quarter and full year FY2026 guidance, execution of strategies, continued demand in the commercial and government aviation markets; market position; anticipated activities and benefits related to new or expanding business relationships; expected contributions and synergies related to acquisitions; expansion of capabilities and operational footprint; opportunities for margin improvement through operations, integration activities and other efficiency initiatives; and continued sales and margin growth, earnings performance, debt management, and capital allocation.
Forward-looking statements often address our expected future operating and financial performance and financial condition, or targets, goals, commitments, and other business plans, and often may also be identified because they contain words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "likely," "may," "might," "plan," "potential," "predict," "project," "seek," "should," "target," "will," "would," or similar expressions and the negatives of those terms.
These forward-looking statements are based on the beliefs of Company management, as well as assumptions and estimates based on information available to the Company as of the dates such assumptions and estimates are made, and are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or those anticipated, depending on a variety of factors, including: (i) factors that adversely affect the commercial aviation industry; (ii) adverse events and negative publicity in the aviation industry; (iii) a reduction in sales to the
For a discussion of these and other risks and uncertainties, refer to our Annual Report on Form 10-K, Part I, "Item 1A, Risk Factors" and our other filings filed from time to time with the
|
|
||||||||
|
|
|
|
|
|||||
|
Condensed consolidated statements of operations (In millions except per share data - unaudited) |
Three months ended
|
|
Nine months ended
|
|||||
|
|
2026 |
2025 |
|
2026 |
2025 |
|||
|
|
|
|
|
|||||
|
Sales |
|
|
|
|
|
|
|
|
|
Cost of sales |
690.4 |
|
546.5 |
|
1,934.7 |
|
1,648.5 |
|
|
Gross profit |
154.7 |
|
131.7 |
|
445.3 |
|
377.5 |
|
|
Provision for (Recovery of) credit losses |
0.5 |
|
(0.2) |
|
2.2 |
|
(0.3) |
|
|
Selling, general, and administrative |
89.8 |
|
61.3 |
|
249.7 |
|
270.3 |
|
|
Earnings from joint ventures |
1.4 |
|
0.5 |
|
4.3 |
|
4.7 |
|
|
Operating income |
65.8 |
|
71.1 |
|
197.7 |
|
112.2 |
|
|
Bargain purchase gain |
35.7 |
|
–– |
|
35.7 |
|
–– |
|
|
Gain on sale of headquarters building |
9.8 |
|
–– |
|
9.8 |
|
–– |
|
|
Gain (Loss) related to sale and exit of businesses, net |
(0.4) |
|
(64.0) |
|
0.2 |
|
(65.3) |
|
|
Interest expense, net |
(17.1) |
|
(18.1) |
|
(54.2) |
|
(55.2) |
|
|
Other expense, net |
(0.7) |
|
(0.1) |
|
(1.0) |
|
(0.4) |
|
|
Income (Loss) before income tax expense (benefit) |
93.1 |
|
(11.1) |
|
188.2 |
|
(8.7) |
|
|
Income tax expense (benefit) |
25.1 |
|
(2.2) |
|
51.2 |
|
12.8 |
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (Loss) per share – Basic |
|
|
|
|
|
|
|
|
|
Earnings (Loss) per share – Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share data used for earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding – Basic |
39.3 |
|
35.4 |
|
37.8 |
|
35.4 |
|
|
Weighted average shares outstanding – Diluted |
39.5 |
|
35.4 |
|
38.0 |
|
35.4 |
|
|
|
||||||||
|
|
|||
|
Condensed consolidated balance sheets (In millions) |
2026 |
|
2025 |
|
|
(unaudited) |
|
|
|
ASSETS |
|
|
|
|
Cash and cash equivalents |
|
|
|
|
Restricted cash |
21.6 |
|
12.7 |
|
Accounts receivable, net |
426.2 |
|
354.8 |
|
Contract assets |
142.3 |
|
140.3 |
|
Inventories, net |
958.2 |
|
809.2 |
|
Other current assets |
136.9 |
|
97.1 |
|
Total current assets |
1,763.7 |
|
1,510.6 |
|
Property, plant, and equipment, net |
163.2 |
|
158.5 |
|
|
840.9 |
|
750.4 |
|
Rotable assets supporting long-term programs |
188.0 |
|
172.4 |
|
Operating lease right-of-use assets, net |
192.8 |
|
93.3 |
|
Other non-current assets |
183.9 |
|
159.4 |
|
Total assets |
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY |
|
|
|
|
Accounts payable |
|
|
|
|
Other current liabilities |
329.0 |
|
251.6 |
|
Total current liabilities |
653.0 |
|
554.7 |
|
Long-term debt |
888.3 |
|
968.0 |
|
Operating lease liabilities |
91.4 |
|
79.6 |
|
Other non-current liabilities |
56.4 |
|
30.7 |
|
Total liabilities |
1,689.1 |
|
1,633.0 |
|
Equity |
1,643.4 |
|
1,211.6 |
|
Total liabilities and equity |
|
|
|
|
|
|||
|
|
|||||||
|
Condensed consolidated statements of cash flows (In millions – unaudited) |
Three months ended
|
|
Nine months ended
|
||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
Cash flows provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities |
|
|
|
|
|
|
|
|
Depreciation and amortization |
21.0 |
|
14.7 |
|
53.5 |
|
43.5 |
|
Stock-based compensation expense |
3.7 |
|
5.6 |
|
13.3 |
|
15.6 |
|
Bargain purchase gain |
(35.7) |
|
–– |
|
(35.7) |
|
–– |
|
Gain on sale of building |
(9.8) |
|
–– |
|
(9.8) |
|
–– |
|
Impairment charge |
–– |
|
63.0 |
|
–– |
|
63.0 |
|
Changes in certain assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
(24.5) |
|
(8.9) |
|
(35.1) |
|
(42.2) |
|
Contract assets |
10.5 |
|
(10.6) |
|
14.2 |
|
(37.8) |
|
Inventories |
(47.2) |
|
(19.2) |
|
(65.5) |
|
(76.6) |
|
Other current assets |
4.4 |
|
(8.1) |
|
(23.9) |
|
(12.9) |
|
Rotable assets supporting long-term programs |
19.0 |
|
(12.1) |
|
(25.6) |
|
(24.2) |
|
Accounts payable and accrued liabilities |
53.7 |
|
(31.1) |
|
25.1 |
|
71.5 |
|
Other |
11.6 |
|
(3.1) |
|
(4.1) |
|
6.3 |
|
Net cash provided by (used in) operating activities |
74.7 |
|
(18.7) |
|
43.4 |
|
(15.3) |
|
|
|
|
|
|
|
|
|
|
Cash flows used in investing activities: |
|
|
|
|
|
|
|
|
Property, plant, and equipment expenditures |
(8.5) |
|
(8.5) |
|
(24.6) |
|
(24.7) |
|
Proceeds from sale of building |
24.8 |
|
4.7 |
|
24.8 |
|
4.7 |
|
Acquisitions, net of cash acquired |
(0.4) |
|
–– |
|
(222.0) |
|
2.9 |
|
Hangar expansion activity, net |
(24.0) |
|
0.5 |
|
(24.5) |
|
(1.6) |
|
Other |
(6.6) |
|
(0.4) |
|
(5.5) |
|
1.8 |
|
Net cash used in investing activities |
(14.7) |
|
(3.7) |
|
(251.8) |
|
(16.9) |
|
|
|
|
|
|
|
|
|
|
Cash flows provided by (used in) financing activities: |
|
|
|
|
|
|
|
|
Short-term borrowings (repayments) on Revolving Credit Facility, net |
(65.0) |
|
35.0 |
|
(232.0) |
|
35.0 |
|
Proceeds from equity offering, net |
–– |
|
–– |
|
273.9 |
|
–– |
|
Proceeds from long-term borrowings, net |
–– |
|
–– |
|
153.0 |
|
–– |
|
Other |
8.9 |
|
5.8 |
|
4.4 |
|
2.0 |
|
Net cash provided by (used in) financing activities |
(56.1) |
|
40.8 |
|
199.3 |
|
37.0 |
|
Increase (Decrease) in cash and cash equivalents |
3.9 |
|
18.4 |
|
(9.1) |
|
4.8 |
|
Cash, cash equivalents, and restricted cash at beginning of period |
96.2 |
|
82.5 |
|
109.2 |
|
96.1 |
|
Cash, cash equivalents, and restricted cash at end of period |
|
|
|
|
|
|
|
|
|
|||||||
|
|
|||||
|
Third-party sales by segment (In millions - unaudited) |
Three months ended
|
|
Nine months ended
|
||
|
|
2026 |
2025 |
|
2026 |
2025 |
|
Parts Supply |
|
|
|
|
$ 794.1 |
|
Repair & Engineering |
265.3 |
215.9 |
|
724.4 |
662.3 |
|
|
167.8 |
162.9 |
|
528.6 |
495.2 |
|
Expeditionary Services |
19.5 |
28.7 |
|
63.1 |
74.4 |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Operating income (loss) by segment (In millions- unaudited) |
Three months ended
|
|
Nine months ended
|
||
|
|
2026 |
2025 |
|
2026 |
2025 |
|
Parts Supply |
|
|
|
|
|
|
Repair & Engineering |
15.1 |
19.0 |
|
58.2 |
62.9 |
|
|
9.4 |
9.6 |
|
33.0 |
23.8 |
|
Expeditionary Services |
2.8 |
6.4 |
|
8.2 |
6.9 |
|
|
78.0 |
80.4 |
|
231.9 |
200.7 |
|
Corporate and other |
(12.2) |
(9.3) |
|
(34.2) |
(88.5) |
|
|
|
|
|
|
|
|
|
|||||
Adjusted net income, adjusted diluted earnings per share, organic adjusted sales growth, adjusted operating margin, adjusted cash flow used in operating activities, adjusted EBITDA, adjusted EBITDA margin, net debt, and net debt to adjusted EBITDA (net leverage) are "non-GAAP financial measures" as defined in Regulation G of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We believe these non-GAAP financial measures are relevant and useful for investors as they illustrate our core operating performance, cash flows, and leverage unaffected by the impact of certain items that management does not believe are indicative of our ongoing and core operating activities. When reviewed in conjunction with our GAAP results and the accompanying reconciliations, we believe these non-GAAP financial measures provide additional information that is useful to gain an understanding of the factors and trends affecting our business and provide a means by which to compare our operating performance and leverage against that of other companies in the industries we compete. These non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.
Our non-GAAP financial measures reflect adjustments for certain items including, but not limited to, the following:
- Costs associated with
U.S. Foreign Corrupt Practices Act ("FCPA") matters that we self-reported to theU.S. Department of Justice and other agencies, including investigation costs and settlement charges. - Expenses associated with recent acquisition activity, including professional fees for legal, due diligence, and other acquisition activities, intangible asset amortization (including amortization of favorable lease assets classified within operating lease right-of-use assets), integration costs, bargain purchase gains, and compensation expense related to contingent consideration and retention agreements.
- Legal judgments and reversals related to or impacted by the
Russia /Ukraine conflict. - Contract termination costs and benefits are comprised of gains and losses that are recognized at the time of modifying, terminating, or restructuring certain customer and vendor contracts, including the impact from the
U.S. government exercising their termination for convenience in the first quarter of fiscal year 2025 for our Mobility Systems business's new-generation pallet contract. - Losses related to our exit from our Indian joint venture, our Landing Gear Overhaul business, and our Composites manufacturing business, including legal fees for the performance guarantee associated with the Composites' A220 aircraft contract.
Adjusted EBITDA is net income before interest income (expense), other income (expense), income taxes, depreciation and amortization, stock-based compensation, and items of an unusual nature including but not limited to business divestitures and acquisitions, FCPA settlement and investigation costs, certain legal judgments, acquisition, integration, and amortization expenses from recent acquisition activity, headquarters relocation activity, product line exits, and significant customer contract terminations.
The Company is not providing a reconciliation of forward-looking financial measures to the most directly comparable forward-looking GAAP measure because the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, unusual gains and losses, the ultimate outcome of pending litigation, the impact and timing of potential acquisitions and divestitures, and other structural changes or their probable significance. Each of the adjustments has not occurred, are out of the Company's control and/or cannot be reasonably predicted. For this reason, the Company is unable to address the probable significance of the unavailable information.
Pursuant to the requirements of Regulation G of the Exchange Act, we are providing the following tables that reconcile the above-mentioned non-GAAP financial measures to the most directly comparable GAAP financial measures:
|
Adjusted net income (In millions - unaudited) |
Three months ended
|
|
Nine months ended
|
||
|
|
2026 |
2025 |
|
2026 |
2025 |
|
Net income (loss) |
|
$ (8.9) |
|
|
|
|
Acquisition, integration, and amortization expenses |
15.5 |
7.5 |
|
36.1 |
23.6 |
|
Bargain purchase gain |
(35.7) |
–– |
|
(35.7) |
–– |
|
Gain on sale of headquarters building |
(9.8) |
–– |
|
(9.8) |
–– |
|
Impairment charge related to product line exit |
4.9 |
–– |
|
4.9 |
–– |
|
Loss on equity investments |
0.3 |
–– |
|
0.3 |
–– |
|
Loss (Gain) related to sale of business/joint venture, net |
0.4 |
64.0 |
|
(0.2) |
63.2 |
|
Severance charges |
–– |
–– |
|
1.0 |
–– |
|
Government COVID-related subsidy liability reversal |
–– |
–– |
|
(0.7) |
–– |
|
FCPA settlement and investigation costs |
–– |
1.1 |
|
–– |
65.3 |
|
Russian bankruptcy court judgment (reversal) |
–– |
(11.1) |
|
–– |
(11.1) |
|
Contract termination cost (benefit) |
–– |
(3.0) |
|
–– |
0.2 |
|
Tax effect on adjustments (a) |
6.0 |
(14.2) |
|
1.1 |
(21.6) |
|
Adjusted net income |
|
|
|
|
|
|
(a) Calculation uses estimated statutory tax rates on non-GAAP adjustments except for the impact of the non-deductible portion of the FCPA settlement charge. |
|
Adjusted diluted earnings per share (unaudited) |
Three months ended
|
|
Nine months ended
|
||
|
|
2026 |
2025 |
|
2026 |
2025 |
|
Diluted earnings (loss) per share |
|
|
|
|
|
|
Acquisition, integration, and amortization expenses |
0.39 |
0.21 |
|
0.95 |
0.66 |
|
Bargain purchase gain |
(0.90) |
–– |
|
(0.94) |
–– |
|
Gain on sale of headquarters building |
(0.25) |
–– |
|
(0.26) |
–– |
|
Impairment charge related to product line exit |
0.12 |
–– |
|
0.13 |
–– |
|
Loss on sale of equity investment |
0.01 |
–– |
|
0.01 |
–– |
|
Loss (Gain) related to sale of business/joint venture, net |
0.01 |
1.80 |
|
(0.01) |
1.78 |
|
Severance charges |
–– |
–– |
|
0.03 |
–– |
|
Government COVID-related subsidy liability reversal |
–– |
–– |
|
(0.02) |
–– |
|
FCPA settlement and investigation costs |
–– |
0.03 |
|
–– |
1.84 |
|
Russian bankruptcy court judgment (reversal) |
–– |
(0.31) |
|
–– |
(0.31) |
|
Contract termination benefit |
–– |
(0.09) |
|
–– |
–– |
|
Tax effect on adjustments (a) |
0.16 |
(0.40) |
|
0.03 |
(0.61) |
|
Adjusted diluted earnings per share |
|
|
|
|
|
|
(a) Calculation uses estimated statutory tax rates on non-GAAP adjustments except for the impact of the non-deductible portion of the FCPA settlement charge. |
|
Adjusted operating margin (In millions - unaudited) |
Three months ended |
||
|
|
|
|
|
|
Sales |
|
|
|
|
Contract termination benefit |
–– |
–– |
(4.0) |
|
Adjusted sales |
|
|
|
|
|
|
|
|
|
Operating income |
$ 65.8 |
|
|
|
Acquisition, integration, and amortization expenses |
15.5 |
14.2 |
7.5 |
|
Impairment charge related to product line exit |
4.9 |
–– |
–– |
|
Russian bankruptcy court judgment (reversal) |
–– |
–– |
(11.1) |
|
Contract termination benefit |
–– |
–– |
(3.0) |
|
FCPA settlement and investigation costs |
–– |
–– |
1.1 |
|
Adjusted operating income |
$ 86.2 |
|
|
|
|
|
|
|
|
Operating margin |
7.8 % |
8.4 % |
10.5 % |
|
Adjusted operating margin |
10.2 % |
10.2 % |
9.7 % |
|
Organic adjusted sales growth for the three months ended (unaudited) |
||
|
|
|
|
|
GAAP sales growth |
24.6 % |
|
|
Impact of contract termination benefit |
0.3 |
|
|
Impact of Landing Gear Overhaul divestiture |
3.6 |
|
|
Impact of acquisitions within the last twelve months |
(14.4) |
|
|
Organic adjusted sales growth |
14.1 % |
|
|
Adjusted cash provided by (used in) operating activities (In millions - unaudited) |
Three months ended
|
|
Nine months ended
|
||
|
|
2026 |
2025 |
|
2026 |
2025 |
|
Cash provided by (used in) operating activities |
|
|
|
$ 43.4 |
|
|
Amounts outstanding on accounts receivable financing program: |
|
|
|
|
|
|
Beginning of period |
28.1 |
23.9 |
|
21.3 |
13.7 |
|
End of period |
(28.2) |
(20.2) |
|
(28.2) |
(20.2) |
|
Adjusted cash provided by (used in) operating activities |
|
|
|
|
|
|
Adjusted EBITDA (In millions - unaudited) |
Three months ended
|
|
Nine months ended
|
|
Year ended |
||
|
|
2026 |
2025 |
|
2026 |
2025 |
|
2025 |
|
Net income (loss) |
|
$ (8.9) |
|
|
|
|
$ 12.5 |
|
Income tax expense (benefit) |
25.1 |
(2.2) |
|
51.2 |
12.8 |
|
26.4 |
|
Other expense, net |
0.7 |
0.1 |
|
1.0 |
0.4 |
|
0.3 |
|
Interest expense, net |
17.1 |
18.1 |
|
54.2 |
55.2 |
|
73.6 |
|
Depreciation and amortization |
20.2 |
14.0 |
|
51.1 |
41.5 |
|
55.2 |
|
Acquisition and integration expenses |
7.5 |
3.5 |
|
18.0 |
11.7 |
|
10.8 |
|
Bargain purchase gain |
(35.7) |
–– |
|
(35.7) |
–– |
|
–– |
|
Gain on sale of headquarters building |
(9.8) |
–– |
|
(9.8) |
–– |
|
–– |
|
Impairment charge related to product line exit |
4.9 |
–– |
|
4.9 |
–– |
|
–– |
|
Losses related to sale of business/joint venture, net |
0.4 |
64.0 |
|
(0.2) |
63.2 |
|
70.3 |
|
Severance charges |
–– |
–– |
|
1.0 |
–– |
|
–– |
|
Government COVID-related subsidy liability reversal |
–– |
–– |
|
(0.7) |
–– |
|
0.8 |
|
FCPA settlement and investigation costs |
–– |
1.1 |
|
–– |
65.3 |
|
65.3 |
|
Russian bankruptcy court judgment |
–– |
(11.1) |
|
–– |
(11.1) |
|
(11.1) |
|
Contract termination cost (benefit) |
–– |
(3.0) |
|
–– |
0.2 |
|
0.2 |
|
Stock-based compensation |
3.7 |
5.6 |
|
13.3 |
15.6 |
|
19.9 |
|
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income margin |
8.0 % |
(1.3) % |
|
|
|
|
|
|
Adjusted EBITDA margin |
12.1 % |
12.0 % |
|
|
|
|
|
|
Net debt (In millions - unaudited) |
|
|
|
|
Total debt |
|
|
|
|
Less: Cash and cash equivalents |
(78.5) |
|
(84.4) |
|
Net debt |
|
|
|
|
Net debt to adjusted EBITDA (In millions - unaudited) |
|
|
Adjusted EBITDA for the year ended |
|
|
Less: Adjusted EBITDA for the nine months ended |
(233.3) |
|
Plus: Adjusted EBITDA for the nine months ended |
285.3 |
|
Adjusted EBITDA for the twelve months ended |
|
|
Net debt at |
|
|
Net debt to Adjusted EBITDA |
2.17 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/aar-reports-third-quarter-fiscal-year-2026-results-302723942.html
SOURCE